Fibromyalgia: management strategies for primary care providers

L M Arnold, K B Gebke, E H S Choy, L M Arnold, K B Gebke, E H S Choy

Abstract

Aims: Fibromyalgia (FM), a chronic disorder defined by widespread pain, often accompanied by fatigue and sleep disturbance, affects up to one in 20 patients in primary care. Although most patients with FM are managed in primary care, diagnosis and treatment continue to present a challenge, and patients are often referred to specialists. Furthermore, the lack of a clear patient pathway often results in patients being passed from specialist to specialist, exhaustive investigations, prescription of multiple drugs to treat different symptoms, delays in diagnosis, increased disability and increased healthcare resource utilisation. We will discuss the current and evolving understanding of FM, and recommend improvements in the management and treatment of FM, highlighting the role of the primary care physician, and the place of the medical home in FM management.

Methods: We reviewed the epidemiology, pathophysiology and management of FM by searching PubMed and references from relevant articles, and selected articles on the basis of quality, relevance to the illness and importance in illustrating current management pathways and the potential for future improvements.

Results: The implementation of a framework for chronic pain management in primary care would limit unnecessary, time-consuming, and costly tests, reduce diagnostic delay and improve patient outcomes.

Discussion: The patient-centred medical home (PCMH), a management framework that has been successfully implemented in other chronic diseases, might improve the care of patients with FM in primary care, by bringing together a team of professionals with a range of skills and training.

Conclusion: Although there remain several barriers to overcome, implementation of a PCMH would allow patients with FM, like those with other chronic conditions, to be successfully managed in the primary care setting.

© 2016 John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
The PCMH: framework and principles. IT, information technology; PCMH, patient‐centred medical home

References

    1. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–72.
    1. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013; 17: 356.
    1. Glennon P. Fibromyalgia syndrome: management in primary care. Rep Rheum Dis 2010; series 6: 1–6.
    1. Arnold LM, Clauw DJ, Dunegan LJ, Turk DC. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc 2012; 87: 488–96.
    1. Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457–64.
    1. Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014; 311: 1547–55.
    1. Hadker N, Garg S, Chandran AB et al. Primary care physicians’ perceptions of the challenges and barriers in the timely diagnosis, treatment and management of fibromyalgia. Pain Res Manag 2011; 16: 440–4.
    1. Choy E, Perrot S, Leon T et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 2010; 10: 102.
    1. Wolfe F, Clauw DJ, Fitzcharles MA et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600–10.
    1. Wolfe F, Clauw DJ, Fitzcharles MA et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011; 38: 1113–22.
    1. Gulec H, Sayar K, Yazici GM. The relationship between psychological factors and health care‐seeking behavior in fibromyalgia patients. Turk Psikiyatri Dergisi 2007; 18: 22–30.
    1. Briones‐Vozmediano E, Vives‐Cases C, Ronda‐Perez E, Gil‐Gonzalez D. Patients’ and professionals’ views on managing fibromyalgia. Pain Res Manag 2013; 18: 19–24.
    1. Hayes SM, Myhal GC, Thornton JF et al. Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude. Pain Res Manag 2010; 15: 385–91.
    1. Robinson RL, Kroenke K, Mease P et al. Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med 2012; 13: 1366–76.
    1. McNett M, Goldenberg D, Schaefer C et al. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross‐sectional study in the United States. Curr Med Res Opin 2011; 27: 673–83.
    1. Robinson RL, Kroenke K, Williams DA et al. Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12‐month findings from the reflections study. Pain Med 2013; 14: 1400–15.
    1. O'Brien EM, Staud RM, Hassinger AD et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Med 2010; 11: 6–15.
    1. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292: 2388–95.
    1. Fillingim RB, King CD, Ribeiro‐Dasilva MC, Rahim‐Williams B, Riley JL III. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009; 10: 447–85.
    1. Vincent A, Lahr BD, Wolfe F et al. Prevalence of fibromyalgia: a population‐based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res 2013; 65: 786–92.
    1. Clauw DJ, Arnold LM, McCarberg BH. The science of fibromyalgia. Mayo Clin Proc 2011; 86: 907–11.
    1. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states–maybe it is all in their head. Best Pract Res Clin Rheumatol 2011; 25: 141–54.
    1. Staud R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother 2012; 12: 577–85.
    1. Crofford LJ. Fibromyalgia. Atlanta, GA: American College of Rheumatology, 2013.
    1. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005; 75: 6–21.
    1. Arnold LM, Hudson JI, Hess EV et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944–52.
    1. Perrot S, Winkelmann A, Dukes E et al. Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract 2010; 64: 1100–8.
    1. Haviland MG, Banta JE, Przekop P. Fibromyalgia: prevalence, course, and co‐morbidities in hospitalized patients in the United States, 1999‐2007. Clin Exp Rheumatol 2011; 29: S79–87.
    1. White LA, Birnbaum HG, Kaltenboeck A et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008; 50: 13–24.
    1. Clark P, Paiva ES, Ginovker A, Salomon PA. A patient and physician survey of fibromyalgia across Latin America and Europe. BMC Musculoskelet Disord 2013; 14: 188.
    1. Ablin J, Fitzcharles MA, Buskila D et al. Treatment of fibromyalgia syndrome: recommendations of recent evidence‐based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Altern Med 2013; 2013: 485272.
    1. Briley M. Drugs to treat fibromyalgia – the transatlantic difference. Curr Opin Investig Drugs 2010; 11: 16–8.
    1. Hauser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome – a systematic review. Eur J Pain 2010; 14: 5–10.
    1. Price C, Lee J, Taylor AM, Baranowski AP. Initial assessment and management of pain: a pathway for care developed by the British Pain Society. Br J Anaesth 2014; 112: 816–23.
    1. Wells AF, Arnold LM, Curtis CE et al. Integrating health information technology and electronic health records into the management of fibromyalgia. Postgrad Med 2013; 125: 70–7.
    1. Lauche R, Hauser W, Jung E et al. Patient‐related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross‐sectional survey. Clin Exp Rheumatol 2013; 31: S34–40.
    1. Annemans L, Wessely S, Spaepen E et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 2008; 58: 895–902.
    1. Hughes G, Martinez C, Myon E, Taieb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006; 54: 177–83.
    1. Staud R. Chronic widespread pain and fibromyalgia: two sides of the same coin? Curr Rheumatol Rep 2009; 11: 433–6.
    1. Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 2014; 34: 1275–80.
    1. Davis JA, Robinson RL, Le TK, Xie J. Incidence and impact of pain conditions and comorbid illnesses. J Pain Res 2011; 4: 331–45.
    1. Ahmad J, Tagoe CE. Fibromyalgia and chronic widespread pain in autoimmune thyroid disease. Clin Rheumatol 2014; 33: 885–91.
    1. Ablin JN, Buskila D. “Real‐life” treatment of chronic pain: targets and goals. Best Pract Res Clin Rheumatol 2015; 29: 111–9.
    1. Podolecki T, Podolecki A, Hrycek A. Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns. Pol Arch Med Wewn 2009; 119: 157–61.
    1. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007; 8: 27.
    1. Mease PJ, Dundon K, Sarzi‐Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 2011; 25: 285–97.
    1. Sanchez RJ, Uribe C, Li H et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 2011; 27: 663–71.
    1. Lee J, Ellis B, Price C, Baranowski AP. Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society. Br J Anaesth 2014; 112: 16–24.
    1. Lyrica (pregabalin) capsules, CV; Lyrica (pregabalin) oral solution, CV, [package insert]. New York, NY: Pfizer Pharmaceuticals, 2013.
    1. Cymbalta (duloxetine delayed‐release capsules) for oral use [package insert]. Indianapolis, IN: Lilly USA, LLC, 2012.
    1. Savella (milnacipran HCl) tablets [package insert]. St. Louis, MO: Forest Laboratories, Inc., 2013.
    1. Traynor LM, Thiessen CN, Traynor AP. Pharmacotherapy of fibromyalgia. Am J Health Syst Pharm 2011; 68: 1307–19.
    1. Smith HS, Bracken D, Smith JM. Pharmacotherapy for fibromyalgia. Frontiers Pharmacol 2011; 2: 17.
    1. Arnold LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006; 8: 212.
    1. Martin SA, Coon CD, McLeod LD, Chandran A, Arnold LM. Evaluation of the fibromyalgia diagnostic screen in clinical practice. J Eval Clin Pract 2014; 20: 158–65.
    1. Masters ET, Mardekian J, Emir B et al. Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilization. J Pain Res 2015; 8: 131–8.
    1. California Heathcare Foundation . Chronic Disease Registries: A Product Review. Oakland, CA, Sacramento, CA: California Healthcare Foundation, 2015.
    1. American College of Physicians . Joint Principles of the Patient Centered Medical Home. Philadelphia, PA: American College of Physicians, 2007.
    1. National Committee for Quality Assurance website . The future of patient‐centered medical homes: foundation for a better health care system. Policy/2014 Comment Letters/The_Future_of_PCMH.pdf (accessed September 22, 2015).
    1. Faber M, Voerman G, Erler A et al. Survey of 5 European countries suggests that more elements of patient‐centered medical homes could improve primary care. Health Aff (Millwood) 2013; 32: 797–806.
    1. Nielson M, Gibson A, Buelt L, Grundy P, Grumbach K. The Patient‐Centered Medical Home's Impact on Cost and Quality. Annual Review of Evidence 2013‐2014. Washington, DC: Patient‐Centered Primary Care Collaborative, 2015.
    1. Tirodkar MA, Morton S, Whiting T et al. There's more than one way to build a medical home. Am J Manag Care 2014; 20: e582–9.
    1. Jackson GL, Powers BJ, Chatterjee R et al. Improving patient care. The patient centered medical home. A systematic review. Ann Intern Med 2013; 158: 169–78.
    1. National Committee for Quality Assurance . NCQA Patient Centered Medical Home. Washington, DC: National Committee for Quality Assurance, 2015.
    1. Bojadzievski T, Gabbay RA. Patient‐centered medical home and diabetes. Diabetes Care 2011; 34: 1047–53.
    1. Wang QC, Chawla R, Colombo CM, Snyder RL, Nigam S. Patient‐centered medical home impact on health plan members with diabetes. J Public Health Manag Pract 2014; 20: E12–20.
    1. Ackroyd SA, Wexler DJ. Effectiveness of diabetes interventions in the patient‐centered medical home. Curr Diabetes Rep 2014; 14: 471.
    1. Taliani CA, Bricker PL, Adelman AM, Cronholm PF, Gabbay RA. Implementing effective care management in the patient‐centered medical home. Am J Manag Care 2013; 19: 957–64.
    1. Randall I, Mohr DC, Maynard C. VHA patient‐centered medical home associated with lower rate of hospitalizations and specialty care among veterans with posttraumatic stress disorder. J Healthc Qual 2014. doi:10.1111/jhq.12092. [Epub ahead of print]
    1. Amiel JM, Pincus HA. The medical home model: new opportunities for psychiatric services in the United States. Curr Opin Psychiatry 2011; 24: 562–8.
    1. Evans L, Whitham JA, Trotter DR, Filtz KR. An evaluation of family medicine residents’ attitudes before and after a PCMH innovation for patients with chronic pain. Fam Med 2011; 43: 702–11.
    1. Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to improve value by organizing around patients’ needs. Health Aff (Millwood) 2013; 32: 516–25.
    1. Peikes DN, Reid RJ, Day TJ et al. Staffing patterns of primary care practices in the comprehensive primary care initiative. Ann Fam Med 2014; 12: 142–9.
    1. Hsu C, Coleman K, Ross TR et al. Spreading a patient‐centered medical home redesign: a case study. J Ambul Care Manag 2012; 35: 99–108.
    1. Patel MS, Arron MJ, Sinsky TA et al. Estimating the staffing infrastructure for a patient‐centered medical home. Am J Manag Care 2013; 19: 509–16.
    1. O'Malley AS, Gourevitch R, Draper K, Bond A, Tirodkar MA. Overcoming challenges to teamwork in patient‐centered medical homes: a qualitative study. J Gen Intern Med 2015; 30: 183–92.
    1. Moran KJ, Burson R. Understanding the patient‐centered medical home. Home Healthc Nurse 2014; 32: 476–81.
    1. Henderson S, Princell CO, Martin SD. The patient‐centered medical home: this primary care model offers RNs new practice‐and reimbursement‐opportunities. Am J Nurs 2012; 112: 54–9.
    1. Berenson RA, Devers KJ, Burton RA. Will the Patient‐Centered Medical Home Transform the Delivery of Health Care? Washington, DC: Urban Institute, 2011.
    1. Schram AP. The patient‐centered medical home: transforming primary care. Nurse Pract 2012; 37: 33–9.
    1. Willard R, Bodenheimer T. The Building Blocks of High‐Performing Primary Care. Oakland, CA: California Healthcare Foundation, 2012.
    1. Cronholm PF, Shea JA, Werner RM et al. The patient centered medical home: mental models and practice culture driving the transformation process. J Gen Intern Med 2013; 28: 1195–201.
    1. Scholle SH, Asche SE, Morton S et al. Support and strategies for change among small patient‐centered medical home practices. Ann Family Med 2013; 11(Suppl. 1): S6–13.
    1. Arnold LM, Stanford SB, Welge JA, Crofford LJ. Development and testing of the fibromyalgia diagnostic screen for primary care. J Womens Health (Larchmt) 2012; 21: 231–9.
    1. Baron R, Perrot S, Guillemin I et al. Improving the primary care physicians’ decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool. Health Qual Life Outcomes 2014; 12: 128.
    1. Fox BP. A PCMH model that works. Reflections on the PBS Special. (accessed June 4, 2015).
    1. Serio CD, Hessing J, Reed B, Hess C, Reis J. The effect of online chronic disease personas on activation: within‐subjects and between‐groups analyses. JMIR Res Protoc 2015; 4: e20.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit